| Agency MBS pledged to counterparties at fair value |
3.84B |
| Agency MBS at fair value |
| Paydowns receivable |
| Available-for-sale Securities, Total |
4.06B |
| Non-Agency MBS at fair value |
| Cash and cash equivalents |
17.1M |
| Interest and dividends receivable |
16.62M |
| Derivative instruments at fair value |
2.02M |
| Prepaid expenses and other |
2.97M |
| Total Assets: |
5.66B |
| Accrued interest payable |
10.36M |
| Repurchase agreements |
3.94B |
| Junior subordinated notes |
37.38M |
| Derivative instruments at fair value |
48.22M |
| Dividends payable on Series A Preferred Stock |
| Dividends payable on Series B Preferred Stock |
| Dividends payable on common stock |
14.37M |
| Payable for securities purchased |
| Accrued expenses and other |
| Total Liabilities: |
4.98B |
| Series B Cumulative Convertible Preferred Stock: par value $0.01 per share; liquidating preference $25.00 per share ($31,437 and $27,525, respectively); 1,257 and 1,101 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively |
| Series A Cumulative Preferred Stock: par value $0.01 per share; liquidating preference $25.00 per share ($46,888 and $46,888, respectively); 1,876 and 1,876 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively |
46.54M |
| Common Stock: par value $0.01 per share; authorized 200,000 shares, 129,747 and 120,901 issued and outstanding at June 30, 2011 and December 31, 2010, respectively |
958K |
| Additional paid-in capital |
966.72M |
| Accumulated other comprehensive income consisting of unrealized losses and gains |
37.45M |
| Accumulated deficit |
-402.88M |
| Total Stockholders' Equity: |
659.66M |
| Total Liabilities and Stockholders' Equity: |
5.66B |
